Safety and Efficacy of Different Dose Levels of Pasireotide in Patients With de Novo, Persistent or Recurrent Cushing's Disease

This study is ongoing, but not recruiting participants.

Study NCT00434148 Information provided by Novartis

First Received: February 9, 2007 Last Updated: November 18, 2009 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	September 2009 (Final data collection date for primary outcome measure)